HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yoshiya Horimoto, Hiroko Onagi, Junichiro Watanabe, Takuo Hayashi
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pathology International
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet